Radiochemotherapy
Showing 1 - 25 of 428
Patient Participation in Lung and Esophageal Cancer Patients
Recruiting
- Lung Cancer
- Esophageal Cancer
-
Guangzhou, ChinaSun Yat-sen University
Aug 25, 2023
Glioblastoma Trial in Berlin (Radiofrequency electromagnetic field treatment)
Recruiting
- Glioblastoma
- Radiofrequency electromagnetic field treatment
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Nov 15, 2023
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Chengdu (Netopitam Palonosetron capsules and dexamethasone)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Netopitam Palonosetron capsules and dexamethasone
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital and Research Institute
Oct 22, 2023
Small Cell Lung Cancer Trial in Nice (acetazolamide in combination with platinum and etoposide-based radiochemo)
Recruiting
- Small Cell Lung Cancer
- acetazolamide in combination with platinum and etoposide-based radiochemotherapy
-
Nice, FranceCentre Antoine Lacassagne
Jan 19, 2023
A Multicenter, Cross-sectional Study on Quality of Life in
Not yet recruiting
- Assessing the Current Quality of Life Status of Esophageal Cancer Patients Who Have Undergone Radical Chemoradiotherapy/Radiotherapy and Long-term Survival
- questionnaire investigation
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Apr 24, 2023
Grade III or Grade IV Glioma Trial (PET imaging with 18F fluciclovine)
Not yet recruiting
- Grade III or Grade IV Glioma
- PET imaging with 18F fluciclovine
- (no location specified)
Jul 27, 2022
Uterine Cervical Tumors, Chemoradiotherapy, Angiogenesis Trial in Wuhan (Hydrochloride anlotinib, cis Platinum/carboplatin,
Recruiting
- Uterine Cervical Neoplasms
- +2 more
- Hydrochloride anlotinib
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
May 17, 2022
Anal Cancer Trial (Salovum and SPC-flakes or corresponding )
Not yet recruiting
- Anal Cancer
- Salovum and SPC-flakes or corresponding placebo
- (no location specified)
Apr 22, 2022
Esophageal Squamous Cell Carcinoma Trial in Hanzhou, Ningbo (Neoadjuvant Radiotherapy, Neoadjuvant Chemotherapy, Immunotherapy)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Neoadjuvant Radiotherapy
- +2 more
-
Hanzhou, Zhejiang, China
- +2 more
Aug 16, 2022
Colorectal Tumor, Effects of Radiation Therapy, Effects of Chemo Trial in China (procedure, radiation, drug)
Suspended
- Colorectal Neoplasm
- +3 more
- Rectectomy
- +3 more
-
Fuzhou, Fujian, China
- +6 more
May 5, 2022
MOLecuLar Signature in Locally Advanced Cervical Cancer Patients
Recruiting
- Cervical Cancer
- Tumor tissue
- Blood sample
-
Rome, ItalyPoliclinico Universitario Agostino Gemelli, IRCCS
Aug 28, 2023
Bladder Cancer Trial in Erlangen (other, radiation, drug)
Recruiting
- Bladder Cancer
- Hyperthermia
- +3 more
-
Erlangen, GermanyDept. of Radiation Therapy, University Hospital Erlangen
May 25, 2022
Epidermoid Carcinoma, Anus Trial in France (radiochemo, Panitumumab)
Completed
- Epidermoid Carcinoma
- Anus
- radiochemotherapy
- Panitumumab
-
Bordeaux, France
- +14 more
Mar 23, 2022
Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Self-administered survey at hospital
- +2 more
- (no location specified)
Oct 3, 2023
Rectal Cancer Trial in France (drug, radiation, procedure)
Active, not recruiting
- Rectal Cancer
- Neoadjuvant chemotherapy Folfirinox, 4 cycles
- +4 more
-
Amiens, France
- +28 more
Sep 27, 2022
Glioblastoma Trial (Dose escalation of radiation dose beyond the therapeutic standard)
Not yet recruiting
- Glioblastoma
- Dose escalation of radiation dose beyond the therapeutic standard
- (no location specified)
May 13, 2023
Hyperthermia, Radiotherapy Trial (Deep Hyperthermia)
Not yet recruiting
- Hyperthermia
- Radiotherapy
- Deep Hyperthermia
- (no location specified)
Sep 27, 2021
Locally Advanced Resectable Esophageal Squamous Cell Carcinoma Trial in Shanghai (SHR-1210)
Not yet recruiting
- Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Sep 5, 2021
Lung Cancer, Head Neck Cancer Trial in France (Biological samples)
Recruiting
- Lung Cancer
- Head and Neck Cancer
- Biological samples
-
Besançon, France
- +3 more
Jul 30, 2021
Glioblastoma Trial (Iodine-125+Chemotherapy, Surgical resection+Radiochemo)
Not yet recruiting
- Glioblastoma
- Iodine-125+Chemotherapy
- Surgical resection+Radiochemotherapy
- (no location specified)
Jun 28, 2021
NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)
Recruiting
- Non-small Cell Lung Cancer
- Hypofractionated radiotherapy
- +4 more
-
Guangzhou, Guangdong, ChinaSun yat-sen university cancer center
Nov 14, 2023
Tumor Metabolism Indicate Radioresistance in Head and Neck
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Radiochemotherapy
-
Lucerne, SwitzerlandDepartment of Otorhinolaryngology - Head and Neck Surgery, Canto
Jan 19, 2022
Esophageal Adenocarcinoma Trial in Cologne, München (Durvalumab 50 MG/ML, Tremelimumab)
Recruiting
- Esophageal Adenocarcinoma
- Durvalumab 50 MG/ML
- Tremelimumab
-
Cologne, Germany
- +1 more
Feb 17, 2022
Esophageal Cancer Trial in Shanghai (radiochemo 1, radiochemo 2, radiochemo 3)
Completed
- Esophageal Cancer
- radiochemotherapy 1
- +5 more
-
Shanghai, Shanghai, Chinathe Ethic Committee of Shanghai General Hospital
Dec 19, 2020